LIPIDOSE
Live / Applied — Third extension granted (statement of use) (as of 14 Dec 2025)
What this means for you
Not registered yet, but its 03 Nov 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97661879
- Mark type
- Stylized text
- Filed
- 03 Nov 2022
- Published for opposition
- 07 May 2024
- Attorney of record
- Sheryl De Luca
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of endotoxemia and sepsis; Intravenous emulsion for injections for the treatment of endotoxemia and sepsis
Owner
- Sepsicure, L.L.C., Fanwood, NJ, US
- Sepsicure, L.L.C., Fanwood, NJ, US
Prosecution history
- 15 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Dec 2025 — SOU EXTENSION 3 GRANTED
- 14 Dec 2025 — SOU EXTENSION 3 FILED
- 14 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Jun 2025 — SOU EXTENSION 2 GRANTED
- 12 Jun 2025 — SOU EXTENSION 2 FILED
- 12 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 31 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Oct 2024 — SOU EXTENSION 1 GRANTED
- 31 Oct 2024 — SOU EXTENSION 1 FILED
- 31 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 02 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 May 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 14 May 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED